Paul P. Dobesh, Pharm.D., FCCP, BCPS

Paul P. Dobesh, Pharm.D., FCCP, BCPS

DobeshAssociate Professor
Department of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
986045 Nebraska Medical Center
Omaha, NE 68198-6045
Phone: (402) 559-3982
Cell: (402) 214-5498
Fax: (402) 559-5673
pdobesh@unmc.edu
 
Teaching Activities:
Dr. Dobesh is the Cardiology Section Coordinator for the Pharmacotherapy II course (PHPR 686).  He also assists with the Drug Literature Evaluation and Research Methods course (PHPR 622) in leading discussions on literature evaluation.  Dr. Dobesh coordinates and serves as the primary preceptor for the Cardiology Clerkship (PHPR 730).

Research Activities/Interests:
Dr. Dobesh is responsible for teaching pharmacy and medical students as well as pharmacy and medical residents and lectures in the area of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and antithrombotic therapy, focusing on real-world utilization and health-economics. He has also published book chapters and several manuscripts in this area.

Recent Publications:

  1. Smith KM, Sorensen T, Connor KA, Dobesh PP, Hoehns JD, Marcus KB, Pass SE, Seybert AL, Shapiro NL. Value of conducting pharmacy residency training – The organizational perspective. Pharmacotherapy 2010;30:490e-510e.
  2. Dobesh PP. The importance of prophylaxis for the prevention of venous thromboembolism in at-risk medical patients. Int J Clin Pract 2010;64:1554-1562.
  3. Dobesh PP, Trujillo. Anticoagulation in the management of ST-segment elevation myocardial infarction. Journal of Pharmacy Practice 2010;23:335-343.
  4. Dobesh PP, Trujillo. Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome. Journal of Pharmacy Practice 2010;23:324-334.
  5. Amin A, Spyropoulos AC, Dobesh P, Shorr A, Hussein M, Mozaffari E, Benner JS. Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE START). J Thromb Thrombolysis 2010;29:326-339.
  6. Dobesh PP, Swahn SM, Peterson EJ, Olsen KM. Statins in sepsis. Journal of Pharmacy Practice 2010;23:38-49.
  7. Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Trujillo TC, Gulseth MP, Nutescu E, Vondracek T. Key articles and guidelines in the treatment of venous thromboembolism. Pharmacotherapy 2009;29:293e-338e.
  8. Bae JP, Dobesh PP, McCollam PL, Khoynezhad A. Potential unrecognized costs of clopidogrel pretreatment in acute coronary syndrome. J Med Econ 2009;12:325-330.
  9. McGuire T, Dobesh P, Klepser D, Rupp M, Olsen K. Clinically important interaction between statin drugs and Clostridium difficile toxin? Medical Hypotheses 2009;73:1045-1047.
  10. Dobesh PP. Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor. Pharmacotherapy 2009;29:1089-1102.